Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04765735 · ClinicalTrials.gov registry record · NA
Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study
A NA study of Chronic Pain, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 9
- Study locations
NCT04765735: Completed NA study of Chronic Pain, sponsored by MedtronicNeuro.
NCT04765735 is a NA study of Chronic Pain that has completed, run by MedtronicNeuro. The registered enrollment target is 52 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (93% lower). The trial reports 9 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04765735, a NA study of Chronic Pain, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 9
- Study locations
Study Summary
This is a prospective, multi-center, randomized, single-blind, cross-over, non-significant risk IDE research study to evaluate the in-clinic performance of a closed-loop algorithm in Spinal Cord Stimulation (SCS) therapy with an ENS device.
Primary Outcome
For every overstimulation sensation brought about by protocol-prescribed activities, subjects will rate the intensity of the sensation using a 5-point Likert scale. The average intensity score during OL and CL periods will be calculated for each subject. If the average intensity score during CL period is less than that from the OL period, the subject is considered as a subject with a reduction in overstimulation sensation during CL vs. OL period. The primary endpoint is the proportion of subject
Conditions Studied
Interventions
- DEVICE Open-loop testing, Closed-loop testing - External Spinal Cord Stimulator (SCS)
Study Locations (9)
Minnesota
- Lakewalk Surgery Center - Duluth
- Nura Research Institute - Edina
- Twin Cities Pain Clinic - Edina
Ohio
- The Ohio State University - Columbus
- Kettering Medical Center - Kettering
- Premier Pain Treatment Institute - Mount Orab
California
- Coastal Pain and Spinal Diagnostics - Carlsbad
Pennsylvania
- Center for Interventional Pain and Spine - Lancaster
South Dakota
- Innovative Pain Center - Watertown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2021-06-29 |
| Phase | NA |
What the finished NCT04765735 record still lists
NCT04765735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Open-loop testing, Closed-loop testing - External Spinal Cord Stimulator (SCS) is the first listed.
NCT04765735 lists 9 locations in 5 states (Minnesota, Ohio, California).
Frequently Asked Questions
What is clinical trial NCT04765735 about?
NCT04765735 is a clinical study titled "Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study". This is a prospective, multi-center, randomized, single-blind, cross-over, non-significant risk IDE research study to evaluate the in-clinic performance of a closed-loop algorithm in Spinal Cord Stimulation (SCS) therapy with an ENS device.
What is the current status of trial NCT04765735?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2021-02-23. Estimated completion is 2021-06-29.
What conditions does trial NCT04765735 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT04765735?
The interventions under investigation include: Open-loop testing, Closed-loop testing - External Spinal Cord Stimulator (SCS) (DEVICE).
Who is sponsoring clinical trial NCT04765735?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04765735 being conducted?
This trial has 9 study locations across California, Minnesota, Ohio, Pennsylvania, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04765735's enrollment target sits among peer trials
52 195th of 301 higher than 107 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI